Remote Biotech AI Clinical Review Analyst

AuraOne; United States; À distance; USD 165 000 - 276 000; Temps partiel

Résumé du poste

AuraOne seeks a remote Biotech Investment Analyst to review AI-driven clinical outputs, grade differential reasoning, dosing logic and guideline adherence, and document corrected reasoning for model training. You’ll flag safety issues and ensure clinicians can validate the output.

Ideal candidates hold an active clinical license, have experience reading patient cases and writing structured assessments, and can commit at least 10 hours per week asynchronously.

Qualifications

• Active or recent license / board certification in clinical review or an adjacent specialty for Biotech Investment Analyst — Drug Asset & Company Assessment work.
• Hands-on clinical experience reading patient cases and writing structured assessments.
• Clear written reasoning that cites guidelines, evidence, or standard of care.

Responsabilités

• Review AI outputs against current clinical review guidelines and standard of care for Biotech Investment Analyst — Drug Asset & Company Assessment assignments.
• Grade differential reasoning, dosing, and red-flag handling on a structured rubric.
• Flag patient-safety issues with severity tags that match clinical-incident taxonomies.
• Capture the corrected clinical reasoning so the modeling team can train on it.

Connaissances

Clinical reasoning

Guideline review

Patient-safety assessment

Structured clinical writing

Clinical review

Description du poste

AuraOne seeks a remote Biotech Investment Analyst to review AI-driven clinical outputs, grade differential reasoning, dosing logic and guideline adherence, and document corrected reasoning for model training. You’ll flag safety issues and ensure clinicians can validate the output.

Ideal candidates hold an active clinical license, have experience reading patient cases and writing structured assessments, and can commit at least 10 hours per week asynchronously.